SEC Form 4 · accession 0001493152-18-016880
enVVeno Medical Corp · NVNO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Marcus W. Robins
Director
Period of report
Nov 27, 2018
Accepted (ET)
Nov 29, 2018 · 5:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001661053
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Restricted Stock unitsF1,F2 | Nov 27, 2018 | A | 29,183 | $2.57 | A | 29,183 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF3 | $2.57 | Nov 27, 2018 | A | 60,000 | A | — | Oct 2, 2021 | Common Stock | 60,000 | 60,000 | D |
Explanation of responses
- F1The Restricted Stock Units ("RSUs") were issued to the Reporting Person on November 27, 2018, in connection with joining the Issuer's board of directors, pursuant to Plan, as amended (the "Plan"). The award is subject to time-based vesting and will vest in equal annual portions on: (i) October 2, 2019; (ii) October 2, 2020; and (iii) October 2, 2021.
- F2Upon vesting, each RSU entitles the Reporting Person to one share of the Issuer's common stock. The Reporting Person has been granted the right to elect to defer actual payment of a vested RSU award, subject to compliance with Internal Revenue Code Section 409A.
- F3The common stock options were issued to the Reporting Person on November 27, 2018, in connection with joining the Issuer's board of directors, pursuant to a grant under the Issuer's Amended and Restated 2016 Omnibus Incentive Plan (the "Plan"), as amended. The award is subject to time-based vesting and will vest in equal quarterly portions over a three (3) year period starting from October 2, 2018.